| Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study B Mehta, S Pedro, G Ozen, A Kalil, F Wolfe, T Mikuls, K Michaud RMD open 5 (1), e000935, 2019 | 137 | 2019 |
| Medications associated with fracture risk in patients with rheumatoid arthritis G Ozen, S Pedro, F Wolfe, K Michaud Annals of the Rheumatic Diseases 78 (8), 1041-1047, 2019 | 90 | 2019 |
| Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis G Ozen, S Pedro, ME Holmqvist, M Avery, F Wolfe, K Michaud Annals of the rheumatic diseases 76 (5), 848-854, 2017 | 88 | 2017 |
| Activation of the JAK/STAT pathway in Behcet's disease. DH Tulunay A, Dozmorov MG, Ture-Ozdemir F, Yilmaz V, Eksioglu-Demiralp E ... Genes and Immunity 16 (2), 170-175, 2015 | 85 | 2015 |
| The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis G Ozen, S Pedro, K Michaud The Journal of rheumatology 48 (5), 648-655, 2021 | 80 | 2021 |
| Fatigue in patients with Behcet's syndrome: relationship with quality of life, depression, anxiety, disability and disease activity B Ilhan, M Can, F Alibaz‐Oner, S Yilmaz‐Oner, O Polat‐Korkmaz, G Ozen, ... International journal of rheumatic diseases 21 (12), 2139-2145, 2018 | 59 | 2018 |
| Risk of serious infection in patients with rheumatoid arthritis treated with biologic versus nonbiologic disease‐modifying antirheumatic drugs G Ozen, S Pedro, BR England, B Mehta, F Wolfe, K Michaud ACR open rheumatology 1 (7), 424-432, 2019 | 58 | 2019 |
| Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases. The Journal of Rheumatology 42 (9), 1661-1666, 2015 | 58 | 2015 |
| Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an … G Ozen, S Pedro, R Schumacher, TA Simon, K Michaud Arthritis research & therapy 21, 1-10, 2019 | 54 | 2019 |
| Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension. Speckle-tracking echocardiographic study. BY Durmus E, Sunbul M, Tigen K, Kivrak T, Ozen G, Sari I, Direskeneli H Herz 40 (4), 709-715, 2015 | 53* | 2015 |
| Fatigue in systemic lupus erythematosus. S Yilmaz-Oner, B Ilhan, M Can, F Alibaz-Oner, O Polat-Korkmaz, G Ozen, ... Zeitschrift für Rheumatologie 76 (10), 2017 | 47 | 2017 |
| Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet’s Disease R Deniz, A Tulunay-Virlan, F Ture Ozdemir, AU Unal, G Ozen, ... Immunological investigations 46 (5), 518-525, 2017 | 46 | 2017 |
| Risk factors for malignancy in systemic sclerosis patients T Kaşifoğlu, Ş Yaşar Bilge, F Yıldız, G Özen, Y Pehlivan, N Yılmaz, ... Clinical rheumatology 35, 1529-1533, 2016 | 42 | 2016 |
| Unmet need in Behcet’s disease: most patients in routine follow-up continue to have oral ulcers F Alibaz-Oner, G Mumcu, Z Kubilay, G Ozen, G Celik, A Karadeniz, M Can, ... Clinical rheumatology 33, 1773-1776, 2014 | 42 | 2014 |
| Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study. G Ozen, N Inanc, AU Unal, S Bas, G Kimyon, B Kisacik, AM Onat, S Murat, ... The Journal of Rheumatology, 2016 | 41 | 2016 |
| Evaluation of left atrial volume and function in systemic sclerosis patients using speckle tracking and real-time three-dimensional echocardiography H Ataş, A Kepez, K Tigen, F Samadov, G Özen, A Cincin, M Sünbül, ... Anatolian Journal of Cardiology 16 (5), 316, 2016 | 39 | 2016 |
| The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough? G Ozen, M Sunbul, P Atagunduz, H Direskeneli, K Tigen, N Inanc Rheumatology 55 (3), 513-522, 2016 | 39 | 2016 |
| Subclinical Atherosclerosis in Systemic Sclerosis: Not Less Frequent Than Rheumatoid Arthritis and Not Detected With Cardiovascular Risk Indices. G Ozen, N Inanc, AU Unal, F Korkmaz, M Sunbul, M Ozmen, S Akar, ... Arthritis care and research, 2016 | 36 | 2016 |
| Trends and determinants of osteoporosis treatment and screening in patients with rheumatoid arthritis compared to osteoarthritis G Ozen, DL Kamen, TR Mikuls, BR England, F Wolfe, K Michaud Arthritis care & research 70 (5), 713-723, 2018 | 25 | 2018 |
| Regional myocardial dysfunction assessed by two-dimensional speckle tracking echocardiography in systemic sclerosis patients with fragmented QRS complexes. BY Tigen K1, Sunbul M2, Ozen G3, Durmus E1, Kivrak T1, Cincin A1, Ozben B1 ... Journal of Electrocardiology 47 (5), 677-83, 2014 | 25 | 2014 |